Ozempic and Mounjaro Linked to Hair Loss: What the New BMJ Study Actually Says

If you or someone you know is on Ozempic, Wegovy, Mounjaro, or Zepbound, you may have already noticed something the packaging doesn't mention — more hair in the shower drain. A large new study published in The BMJ has now put real numbers behind what many patients have been quietly reporting for months: GLP-1 medications appear to raise the risk of hair loss.

Here's what the research found, why it likely happens, and what you can do about it — whether you're on these medications or simply losing more hair than usual for any reason.

What the Study Found

Researchers from the University of Pennsylvania analysed electronic health records of tens of thousands of adults with type 2 diabetes, tracking patients between 2019 and 2024. They compared people taking GLP-1 receptor agonists — the drug class that includes semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — against patients taking two other common diabetes medication classes, SGLT-2 inhibitors and DPP-4 inhibitors.

The study — led by Dr Huilin Tang and colleagues at Penn Medicine's Perelman School of Medicine — compared 12,004 people newly starting GLP-1 drugs against 15,221 people starting SGLT-2 inhibitors, and a separate group of 11,964 GLP-1 initiators against 11,238 people starting DPP-4 inhibitors. To make the comparison fair, the team used a "target trial emulation" design and statistically balanced the groups for age, sex, ethnicity, BMI, and existing health conditions before comparing outcomes.

The results showed a clear pattern:

• People on GLP-1 drugs had roughly a 37% higher risk of hair loss compared with those on SGLT-2 inhibitors (hazard ratio 1.37, 95% CI 1.08–1.73).
  

• Compared with DPP-4 inhibitors, the risk was about 68% higher.
  

• Most of the hair loss recorded was non-scarring alopecia — meaning the hair follicles remain intact, so regrowth is possible once the underlying trigger is addressed.
  

• The overall absolute risk was still small, working out to somewhere between three and nine extra cases per 1,000 people each year.
  

• The researchers noted the results held up consistently across multiple sensitivity and subgroup analyses, which strengthens confidence that this isn't a statistical fluke.
  

The findings were significant enough that the U.S. FDA has confirmed it is formally reviewing hair loss as a potential safety signal for these drugs, even though it isn't currently listed as an official side effect on the label. Dermatologists commenting on the study, including Dr Emma Guttman-Yassky of Mount Sinai, have noted that the findings reinforce the value of involving a dermatologist early when starting GLP-1 therapy, given how much hair loss concerns patients even when it isn't medically dangerous.

Why Would a Weight-Loss Drug Cause Hair Loss?

The study wasn't designed to prove direct cause and effect, but researchers point to one likely explanation: rapid weight loss itself, not the drug molecule acting on hair follicles directly.

This ties into something dermatologists have known for decades, long before GLP-1 drugs existed — a condition called telogen effluvium. Any major shock to the body (crash dieting, illness, surgery, extreme stress, sudden calorie restriction, or fast weight loss) can push a larger-than-usual number of hair follicles into their "resting" phase at the same time. A few months later, all of those resting hairs shed together, which shows up as noticeably increased hair fall.

The encouraging part: because the follicle itself isn't damaged, this type of shedding is usually temporary and reversible once the body stabilises and the hair gets the nourishment and care it needs to re-enter its growth phase.

This lines up with separate research outside the BMJ study. Reviews of hair loss after bariatric surgery — another route to rapid weight loss — have found similar patterns, with telogen effluvium often linked to falling iron, zinc, protein, and B12 levels as food intake drops sharply. Since GLP-1 drugs work precisely by suppressing appetite, doctors treating patients on these medications have flagged the same nutritional cascade as a likely contributor, independent of any direct drug effect on the scalp.

Should You Be Worried?

A few things are worth keeping in perspective:

1. The absolute risk is low. Even in the higher-risk comparison, we're talking about single-digit extra cases per 1,000 people per year — not a mass-shedding event for everyone on these drugs.

2. This isn't a reason to panic or stop medication on your own. If you're on a GLP-1 drug for diabetes or weight management and notice hair thinning, talk to your prescribing doctor rather than discontinuing treatment abruptly.

3. It's a signal to pay closer attention to hair and scalp care, especially if you're losing weight quickly for any reason — medication-assisted or not.
   

Supporting Your Hair Naturally During Rapid Weight Loss

Whether the trigger is a GLP-1 medication, a strict diet, stress, or simply age, hair that's shedding from a telogen effluvium-type response responds well to consistent scalp care, nourishment, and patience. A few habits that genuinely help:

• Adequate protein and micronutrients — hair is largely made of protein (keratin), and crash dieting or very low intake can starve follicles of what they need to produce strong hair.

• Gentle handling — reduce heat styling, tight hairstyles, and harsh brushing while hair is in a fragile shedding phase.

• Scalp nourishment — a clean, well-circulated scalp with balanced pH creates a better environment for follicles to re-enter their growth phase.

• Consistency over quick fixes — hair cycles are slow. Most natural interventions need 8–12 weeks of regular use before visible change.
  

This is where a good traditional hair oil earns its place in a routine — not as a miracle cure, but as steady, daily scalp care.

Where Aarogya Kesha Fits In

At Aarogya Naturals, we formulated Aarogya Kesha around this exact principle: consistent, gentle, Ayurveda-rooted scalp care using clean ingredients — no harsh chemicals or preservatives, and pH-balanced for the scalp.

Aarogya Kesha is blended from responsibly sourced herbs including Lavender and Chameli (Jasmine), prepared under the supervision of licensed chemists, and is designed to:

• Visibly reduce hair fall and dandruff

• Repair split-ends and fragmented hair strands

• Support thicker, longer, more voluminous-looking hair growth over time

• Help delay premature greying

• Leave hair smoother and silkier, without a greasy residue, thanks to quick absorption
  

There's also a growing body of independent research behind some of these ingredients. A 2016 study in Toxicological Research found that topical lavender oil increased hair follicle number and dermal thickness in an animal model, with effects approaching those of a standard topical hair-growth treatment. More recently, a 2024 randomised, placebo-controlled human trial found that a rosemary–lavender oil blend measurably improved hair growth rate, thickness, and density, and reduced hair fall by over 40% compared with a control oil. This kind of evidence doesn't mean any single oil "cures" hair loss — but it does support consistent scalp oiling with well-chosen botanicals as a legitimate part of a hair-care routine, not just a folk remedy.

To be clear: Aarogya Kesha isn't a treatment for any specific medical condition, and it won't reverse hair loss caused by an underlying hormonal or medical issue overnight. But for anyone whose hair is under extra stress right now — whether from a GLP-1 medication, a demanding diet, or just day-to-day wear and tear — it's a simple, natural way to give your scalp the daily care it needs while your body resets.

Conclusion

The BMJ study is a useful reminder, not a reason for alarm: popular GLP-1 drugs like Ozempic and Mounjaro carry a modest, likely temporary hair loss risk, probably linked to rapid weight loss rather than the drug itself. If you're experiencing it, the right response is usually patience, good nutrition, gentle care, and a conversation with your doctor — not stopping medication abruptly.

And if you're looking for a natural way to support your scalp through it, Aarogya Kesha is worth adding to your routine.

FAQs

Does Ozempic definitely cause hair loss? 

The study shows a strong association, not proof of direct cause. Researchers believe rapid weight loss, rather than the drug itself, is the likely trigger.

Is hair loss from GLP-1 drugs permanent? 

Most of the hair loss identified in the study was non-scarring, meaning follicles remain intact and regrowth is possible once the shedding phase passes.

Should I stop taking Ozempic or Mounjaro if I notice hair thinning? 

No — speak with your doctor first. The absolute risk of hair loss is small, and stopping medication without medical advice can affect your underlying condition.

How long does medication-related hair shedding usually last? 

Telogen effluvium-type shedding typically lasts a few months and often resolves on its own, especially with good nutrition and scalp care.

This article is for general informational purposes and is not a substitute for professional medical advice. If you're concerned about hair loss, please consult a doctor or dermatologist.

Sources & References

Government & Regulatory Sources

1. U.S. Food and Drug Administration — FDA has publicly confirmed it is evaluating hair loss as a potential safety signal for GLP-1 receptor agonists; see the FDA's general resource on reporting drug side effects via MedWatch for how such safety signals are tracked and reviewed.
   

Peer-Reviewed & News Sources

2. Tang H, et al. "Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation." The BMJ, 2026; 394:e100077. DOI: 10.1136/bmj-2026-100077

3. BMJ Group press release: "GLP-1 diabetes drugs linked to increased risk of hair loss"

4. ScienceDaily: "Ozempic and Mounjaro linked to a surprising hair loss risk", July 2026

5. Healio: "GLP-1 therapy associated with hair loss in people with type 2 diabetes", July 2026

6. ScienceAlert: "Common Weight-Loss Drugs Have Been Linked to a Higher Risk of Hair Loss"

7. Reuters/The Irish Times: "Weight-loss drugs linked to increased risk of hair loss, researchers say" — notes UK regulator (MHRA) adverse event reports and FDA safety-signal evaluation

8. Lee BH, et al. "Hair Growth-Promoting Effects of Lavender Oil in C57BL/6 Mice." Toxicological Research, 2016.

9. Randomised controlled trial on rosemary–lavender oil (Rosmagain™) for hair regrowth and scalp health, PMC (U.S. National Library of Medicine), 2024 — full text

10. Scoping review: "Telogen Effluvium in Patients after Bariatric Surgery" — nutritional deficiency and rapid weight loss as drivers of hair shedding.